Who Benefits Most from Advanced Hybrid Closed Loop Therapy in Pregnancy Across Different Subgroups: A Secondary Analysis of the Randomized Controlled CRISTAL Trial
AHCL therapy improved glycemic management in pregnant women with baseline HbA1c <7.0%, in women without prior AHCL use, and in women without higher education, indicating that AHCL might particularly benefit these subgroups.
Authors
- Gerd Vanhaverbeke (ORCID: https://orcid.org/0000-0001-6986-6695)
- Youri Taes
- Nancy Van Wilder
- Xavier-Philippe Aers
- Marc Peeters (ORCID: https://orcid.org/0000-0003-4969-2303)
- Rebecca C. Painter (ORCID: https://orcid.org/0000-0001-9336-6033)
- Joke Cuypers
- Joke Marlier (ORCID: https://orcid.org/0000-0002-9500-608X)
- Sarah E. Siegelaar (ORCID: https://orcid.org/0000-0002-6928-8984)
- Liesbeth Van Huffel
- Frank Nobels (ORCID: https://orcid.org/0000-0002-8058-8734)
- Annouschka Laenen (ORCID: https://orcid.org/0000-0002-1371-442X)
- Kaat Beunen (ORCID: https://orcid.org/0000-0003-3557-0022)
- Katrien Benhalima (ORCID: https://orcid.org/0000-0002-3325-0263)
- Vanessa Preumont
- Dominique Ballaux
- Dahae Lee (ORCID: https://orcid.org/0000-0003-2180-5871)
- Ina Geerts (ORCID: https://orcid.org/0009-0004-2803-7013)
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- AZ Groeninge (BE)
- Ghent University Hospital (BE)
- Erasmus MC (NL)
- Onze Lieve Vrouwziekenhuis Hospital (BE)
- AZ Sint-Jan (BE)
- Vlaamse Vereniging voor Obstetrie en Gynaecolo (BE)
- AZ Turnhout (BE)
- Imelda Hospital (BE)
- AZ Delta (BE)
- Flanders Environment Agency (BE)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
- Erasmus University Rotterdam (NL)
- KU Leuven (BE)
Publication Details
- Journal
- Diabetes Technology & Therapeutics
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1177/15209156251379505
- Citations
- 1
- Primary Topic
- Assisted Reproductive Technology and Twin Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 3.49